During the past decade, Clinical Pharmacology of Miami conducted 133 clinical trials. In the 10-year time frame, 133 clinical trials started and 47 clinical trials were completed, i.e. on average, 35.3% percent of trials that started reached the finish line to date. In the past 5 years, 77 clinical trials started and 30 clinical trials were completed. i.e. 39% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Pharmacology of Miami" #1 sponsor was "Shire" with 18 trials, followed by "Eli Lilly and Company" with 12 trials sponsored, "Bristol-Myers Squibb" with 10 trials sponsored, "Merck Sharp & Dohme LLC" with 9 trials sponsored and "Bayer" with 9 trials sponsored. Other sponsors include 117 different institutions and companies that sponsored additional 78 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Pharmacology of Miami" #1 collaborator was "Basilea Pharmaceutica International Ltd" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 2 trials as a collaborator, "Covance" with 2 trials as a collaborator and "Integrium" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Pharmacology of Miami" are "Hepatic Impairment" (32 trials), "Healthy Volunteers" (22 trials), "Healthy" (17 trials), "Renal Impairment" (15 trials) and "Diabetes Mellitus, Type 2" (7 trials). Many other conditions were trialed in "Clinical Pharmacology of Miami" in a lesser frequency.

Most popular intervention types in "Clinical Pharmacology of Miami" are "Drug" (173 trials), "Biological" (5 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "CTP-543" (6 trials), "SSP-004184SS" (4 trials), "ASP015K" (3 trials) and "Midazolam" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Pharmacology of Miami" are 164 trials for "All" genders, 9 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Pharmacology of Miami". undefined are not yet recruiting, 13 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 144 completed trials in Clinical Pharmacology of Miami, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Pharmacology of Miami, 148 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".